Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Future Medicinal Chemistry
|
November 20, 2012
Current trends in epigenetic drug discovery
Diana A Stolfa, Oliver Einsle, Wolfgang Sippl, et al.
Chemmedchem
|
May 26, 2012
Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors
Diana A Stolfa, Angela Stefanachi, Julia M Gajer, et al.
Bioorganic & Medicinal Chemistry
|
April 15, 2008
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro
Saverio Cellamare, Angela Stefanachi, Diana A Stolfa, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5
Benjamin Maurer, Tobias Rumpf, Michael Scharfe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 27, 2018
The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids
Carsten Ginsel, Birte Plitzko, Danilo Froriep, et al.
Journal of Translational Medicine
|
January 28, 2015
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Letizia Porcelli, Gabriella Guida, Anna E Quatrale, et al.
Journal of Molecular Biology
|
March 25, 2014
Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni
Diana A Stolfa, Martin Marek, Julien Lancelot, et al.
Plos Pathogens
|
October 3, 2013
Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni
Martin Marek, Srinivasaraghavan Kannan, Alexander-Thomas Hauser, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Future Medicinal Chemistry
|
November 20, 2012
Current trends in epigenetic drug discovery
Diana A Stolfa, Oliver Einsle, Wolfgang Sippl, et al.
Chemmedchem
|
May 26, 2012
Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors
Diana A Stolfa, Angela Stefanachi, Julia M Gajer, et al.
Bioorganic & Medicinal Chemistry
|
April 15, 2008
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro
Saverio Cellamare, Angela Stefanachi, Diana A Stolfa, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5
Benjamin Maurer, Tobias Rumpf, Michael Scharfe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 27, 2018
The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids
Carsten Ginsel, Birte Plitzko, Danilo Froriep, et al.
Journal of Translational Medicine
|
January 28, 2015
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Letizia Porcelli, Gabriella Guida, Anna E Quatrale, et al.
Journal of Molecular Biology
|
March 25, 2014
Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni
Diana A Stolfa, Martin Marek, Julien Lancelot, et al.
Plos Pathogens
|
October 3, 2013
Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni
Martin Marek, Srinivasaraghavan Kannan, Alexander-Thomas Hauser, et al.
Page
of 1